QA: Corbus Pharmaceuticals Holdings Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001595097_2018_Corbus_Pharmaceuticals_Holdings_Inc.pdf

Logs

Graph

Absolute values for 0001595097, Corbus Pharmaceuticals Holdings Inc

  xvar xval
0 AssetsCurrent 65,504,730
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,432,655
3 remainder_Assets 40,776
4 LiabilitiesCurrent 8,204,675
5 LiabilitiesNoncurrent 375
6 remainder_Liabilities 989,550
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,964,046
9 ResearchAndDevelopmentExpense 26,038,965
10 remainder_Expenses 0
11 remainder_Revenues 2,440,195
12 remainder_NetIncome 141,204
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 66,978,161
1 Liabilities 9,194,600
2 Expenses 35,003,011
3 Revenues 2,440,195
4 StockholdersEquity 57,783,561
5 NetIncome -32,421,612
6 ComprehensiveNetIncome -32,421,612
7 BaseVar 56,878,586
8 EconomicCapitalRatiobeforeLimitedLiability 2.46
9 EconomicCapitalRatio 3.33

Edgar->Model Mapping

Feature Distribution

Change over Time